Skip to main content
OpenTrials

Clinical trial condition

First or Second Line HER2-negative Breast Cancer

Explore clinical trials studying First or Second Line HER2-negative Breast Cancer. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

First or Second Line HER2-negative Breast Cancer trial results

Completed

Effect of Zoledronic Acid as Anti-Cancer Treatment in Metastatic Breast Cancer Patients

NCT01129336

Conditions
Breast Diseases, Breast Neoplasms, First or Second Line HER2-negative Breast Cancer, +10 more
Locations
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • Clopton Clinic Jonesboro, Arkansas, United States
  • Hematology Oncology Services of Arkansas Little Rock, Arkansas, United States
  • Kaiser Permanente Medical Group Kaiser Permanente - Hawaii Anaheim, California, United States
View all 33 locations
View Trial Details

Related conditions